Retinopathy of Prematurity - Pathophysiologic Mechanisms and New Treatment Options

被引：0
|
作者：
Stahl, A. [1 ]
Aisenbrey, S. [2 ]
Krohne, T. U. [3 ]
机构：
[1] Univ Freiburg, Univ Augenklin, D-79106 Freiburg, Germany
[2] Univ Tubingen, Univ Augenklin, Tubingen, Germany
[3] Univ Bonn, Univ Augenklin, Bonn, Germany
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2012年 / 229卷 / 10期
关键词：
retina; retinopathy of prematurity; ROP; ENDOTHELIAL GROWTH-FACTOR; DIODE-LASER TREATMENT; LONGITUDINAL POSTNATAL WEIGHT; PROLIFERATIVE RETINOPATHY; RETINAL NEOVASCULARIZATION; INTRAVITREAL BEVACIZUMAB; VEGF; PREDICTOR; INFANTS; GAIN;
D O I：
10.1055/s-0032-1315247
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Retinopathy of prematurity (ROP), like other angioproliferative retinal disorders, has witnessed the advent of anti-VEGF therapy in clinical practice. The first report from the BEAT-ROP study published in 2011 represents the first comparison of anti-VEGF therapy versus conventional laser treatment in a randomised controlled trial. This review article investigates these novel aspects of ROP therapy from a pathophysiological angle and delineates the stages of ROP in which anti-VEGF treatment appears as a reasonable option. Furthermore, the novel chances of anti-VEGF therapy are being weighed against some still unanswered questions and novel study concepts are being presented.
引用
收藏
页码：1024 / 1029
页数：6
相关论文
共 50 条
  • [31] Emerging Treatments for Retinopathy of Prematurity
    Mantagos, Iason S.
    Vanderveen, Deborah K.
    Smith, Lois E. H.
    SEMINARS IN OPHTHALMOLOGY, 2009, 24 (02) : 82 - 86
  • [32] Laser treatment for retinopathy of prematurity
    Houston, Samuel K.
    Wykoff, Charles C.
    Berrocal, Audina M.
    Hess, Ditte J.
    Murray, Timothy G.
    LASERS IN MEDICAL SCIENCE, 2013, 28 (02) : 683 - 692
  • [33] The treatment and risk factors of retinopathy of prematurity in neonatal intensive care units
    Leng, Yunxia
    Huang, Wenzhi
    Ren, Guoliang
    Cai, Cheng
    Tan, Qingbiao
    Liang, Yuqin
    Yang, Weizhong
    Gao, Zongyin
    BMC OPHTHALMOLOGY, 2018, 18
  • [34] Educational paper Retinopathy of prematurity
    Casteels, Ingele
    Cassiman, Catherine
    Van Calster, Joachim
    Allegaert, Karel
    EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (06) : 887 - 893
  • [35] Ophthalmological screening for retinopathy of prematurity
    Oberacher-Velten, I.
    Segerer, H.
    Helbig, H.
    OPHTHALMOLOGE, 2012, 109 (12): : 1182 - 1188
  • [36] The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China
    Meng, Qing-Yu
    Cheng, Yong
    Zhao, Ming-Wei
    Liang, Jian-Hong
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (07) : 1146 - 1150
  • [37] New insights in diagnosis and treatment for Retinopathy of Prematurity
    Linda A. Cernichiaro-Espinosa
    Francisco J. Olguin-Manriquez
    Andree Henaine-Berra
    Gerardo Garcia-Aguirre
    Hugo Quiroz-Mercado
    Maria A. Martinez-Castellanos
    International Ophthalmology, 2016, 36 : 751 - 760
  • [38] New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics
    Ryu, Juhee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [39] New Therapeutic Approaches in the Treatment of Retinopathy of Prematurity
    Jandeck, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2009, 226 (11) : 914 - 919
  • [40] Current and Future Trends in Treatment of Severe Retinopathy of Prematurity
    Wallace, David K.
    Wu, Katherine Y.
    CLINICS IN PERINATOLOGY, 2013, 40 (02) : 297 - +
12345